ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد

Categorization of certain medications by their effects on body weight[1]

Categorization of certain medications by their effects on body weight[1]
Medication classes Can cause weight loss Can cause weight gain
Anticonvulsant medications
  • Topiramate
  • Zonisamide
  • Lamotrigine
  • Carbamazepine
  • Gabapentin
  • Pregabalin
  • Valproate
  • Vigabatrin
Antidepressants
  • Bupropion
  • Monoamine oxidase inhibitors (eg, phenelzine)
  • Some tricyclic antidepressants (nortriptyline, amitriptyline, doxepin, imipramine)
  • Some SSRIs (paroxetine, citalopram, escitalopram)
  • Mirtazapine
Antipsychotics[2]
  • Ziprasidone
  • Thioridazine
  • Olanzapine
  • Risperidone
  • Clozapine
  • Quetiapine
  • Haloperidol
  • Aripiprazole
Diabetes medications
  • Glucagon-like peptide 1 receptor agonists (eg, semaglutide, liraglutide)
  • Sodium-glucose cotransporter 2 inhibitors (eg, empagliflozin)
  • Alpha-glucosidase inhibitors (eg, acarbose)
  • Tirzepatide
  • Pramlintide
  • Metformin
  • Insulin
  • Sulfonylureas (eg, glipizide)
  • Thiazolidinediones (eg, pioglitazone)
  • Meglitinides (eg, repaglinide)
Glucocorticoids  
  • All agents (eg, prednisone, dexamathasone)
Mood-stabilizing agents  
  • Lithium
Progestins  
  • All agents (eg, medroxyprogesterone)
Stimulants
  • Methylphenidate
  • Amphetamine
  • Lisdexamfetamine
  • Dextroamphetamine[3, 4]
 
Others  
  • Cyproheptadine (antihistamine)
  • Terazosin (alpha adrenergic receptor blocker)
  • Propranolol (beta adrenergic receptor blocker)
SSRIs: selective serotonin reuptake inhibitors.
References:
  1. Tsai AG, Wadden TA. In the clinic: Obesity. Ann Intern Med 2013; 159:ITC3-1.
  2. Campforts B, Drukker M, Crins J, et al. Association between antipsychotic medication and clinically relevant weight change: Meta-analysis. BJPsych Open 2023; 9:e18.
  3. Catalá-López F, Hutton B, Núñez-Beltrán A, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLoS One 2017; 12:e0180355.
  4. Goldfield GS, Lorello C, Doucet E. Methylphenidate reduces energy intake and dietary fat intake in adults: A mechanism of reduced reinforcing value of food? Am J Clin Nutr 2007; 86:308.

Adapted from: Bray GA, Ryan DH. Medical therapy for the patient with obesity. Circulation 2012; 125:1695.

Graphic 85807 Version 12.0